Delivery layer

Atraxis™: membrane-interactive delivery.

The delivery architecture designed to place NeoTag™ signals onto the tumor membrane, without editing the genome or using viral vectors.

Explore the platform

Delivery built on membrane fusion.

Atraxis™ is built around vesicle-mediated membrane fusion, an established biological mechanism. A carrier vesicle is designed to merge with the tumor cell’s outer membrane and deposit the signal at the surface. Its adaptive capabilities are designed to add logic-gated, selective fusion and payload co-delivery.

Vesicle-mediated membrane fusion
Non-genetic and non-viral
Controlled surface editing
Adaptive, logic-gated selectivity
Back to the platform
Established mechanism

Built on vesicle-mediated membrane fusion, a known biological process.

Clean by design

No genome editing and no viral vectors.

Controlled editing

Designed for stable, controlled, and potentially reversible surface editing.

Selective fusion

Logic-gated, context-dependent activation rather than constant delivery.

Payload co-delivery

Designed to co-deliver payloads to support combination strategies.

Orientation control

Orientation-controlled display for spatial and temporal selectivity.

What to know about
Atraxis™

Where it fits

Atraxis™ is the delivery layer, carrying NeoTag™ signals to the tumor surface under the governance of AegisCore™ and StratIQ™.

Current status

Core filings complete. Efficient, selective fusion is a primary objective of our preclinical work.

An important note

LurexBio is a preclinical-stage company. Platform descriptions reflect design intentions and scientific hypotheses, not demonstrated results.

Delivery layer · 2 of 4

How Atraxis™ works

Part of one operating system

  1. 01Carriers in transit
  2. 02Docking
  3. 03Fusion
  4. 04Deposition
  5. 05Selective fusion

Step 01

Carriers in transit

Lipid vesicles carry their cargo toward the tumor.

Step 02

Docking

A vesicle meets the tumor membrane, and the two surfaces press together at the point of contact.

Step 03

Fusion

The vesicle is designed to merge with the tumor membrane through vesicle-mediated membrane fusion.

Step 04

Deposition

Once fused, the cargo is placed on the tumor surface, leaving new surface markers in position.

Step 05

Selective fusion

Adaptive precision control is designed to favor fusion with tumor cells while leaving healthy cells alone.

Illustrations are conceptual.

Explore the other layers

Designed to install a recognizable immune marker on the tumor cell surface.

Programmable safety and activation logic that governs when, where, and how the platform acts.

The governing decision framework that coordinates every layer as one system.